RAPISCAN

This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Italy, Lithuania, Poland, Romania, United Kingdom

Active ingredients

The drug RAPISCAN contains one active pharmaceutical ingredient (API):

1 Regadenoson UNII 2XLN4Y044H - REGADENOSON

Regadenoson is a low affinity agonist (Ki ≈ 1.3 μM) for the A2A adenosine receptor, with at least 10-fold lower affinity for the A1 adenosine receptor (Ki >16.5 μM), and very low, if any, affinity for the A2B and A3 adenosine receptors. Activation of the A2A adenosine receptor produces coronary vasodilation and increases coronary blood flow (CBF). Read about Regadenoson

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RAPISCAN Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C01EB21		C Cardiovascular system → C01 Cardiac therapy → C01E Other cardiac preparations → C01EB Other cardiac preparations
Discover more medicines within C01EB21

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1493939
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 110643001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 506963
Country: FR	Base de données publique des médicaments	Identifier(s): 69075222
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 194865
Country: HK	Department of Health Drug Office	Identifier(s): 66576
Country: IT	Agenzia del Farmaco	Identifier(s): 042729018
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1056396
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100315321
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64487001